Cure My Disease

Don't miss your cure!

 Log in / Sign up

Diabetes may weaken Kids' bones, new study reveals

NCT ID NCT04289727

Knowledge-focused Sponsor: Columbia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how type 1 diabetes affects bone health in children and teens. Researchers compared bone density and structure in 86 children with and without diabetes using special scans. The goal was to understand if diabetes makes bones more fragile, which could lead to better ways to protect bone health in the future.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors understand why people with type 1 diabetes have weaker bones and guide future prevention or treatment.
What could go wrong
This is an observational study, not a treatment trial. It only measures bone differences and does not test any intervention, so it cannot directly improve bone health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

86 people

The number who actually took part.

Started

Jan 2020

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

40 children and adolescents between the age of 8 to 14 years with type 1 diabetes and 40 children and adolescents between the age of 8 to 14 years without type 1 diabetes.

Ages

8 to 14 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (T1D and Controls): \- Children within 2 years preceding the onset of the pubertal growth spurt Inclusion Criteria (T1D participants): \- documentation of β-cell autoimmunity and need for insulin replacement Exclusion Criteria: * Estimated glomerular filtration rate (eGFR)\< 60 ml/mim * 25(OH)D level \< 20 ng/ml. * Celiac disease * Autoimmune thyroid disease * Addison's disease * History of pathological fractures \-- Disorders associated with altered skeletal structure or function * Bone active drugs in past year * Diabetes of other or unclear etiology

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE1DIABETES

Contacts and locations

Locations

  • Columbia University Medical Center-Harkness Pavillion

    New York, New York, 10032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.